What is the ticker symbol for Abivax S.A.?

Abivax S.A. trades under the ticker ABVX on NASDAQ.

What sector does Abivax S.A. operate in?

Abivax S.A. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABVX in a portfolio?

PortView shows ABVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Abivax S.A. (ABVX) Stock Analysis

NASDAQHealthcareBiotechnology

$111.90-1.56%

1-year price historyRange $72.50 – $145.31

52-week range$111.90

$69.81$148.83

What Abivax S.A. does

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19. This compound is also being evaluated in Phase IIa studies for rheumatoid arthritis and has successfully completed Phase IIa trials demonstrating viral remission in patients with HIV. Additionally, the company is advancing ABX 196, an immune-boosting candidate, through Phase 1/2 clinical trials targeting hepatocellular cancer. Abivax also conducts research initiatives for conditions like Dengue fever, influenza, and respiratory syncytial virus. The company has secured license agreements with key French scientific bodies, including the National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. Founded in 2013, Abivax S.A. maintains its headquarters in Paris, France.

Key metrics

Market cap

$8.22B

P/E (TTM)

-58.65

EPS (TTM)

$-1.91

Beta

-0.23

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$124.02

200-day avg

$119.33

52-week high

$148.83

52-week low

$69.81

CEO

Marc de Garidel

ETFs linked to ABVX

Broad-market and Healthcare sector ETFs an investor holding Abivax S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ABVX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ABVX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Abivax S.A.?: Abivax S.A. trades under the ticker ABVX on NASDAQ.
Which exchange is ABVX listed on?: ABVX is listed on NASDAQ.
What sector does Abivax S.A. operate in?: Abivax S.A. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ABVX in a portfolio?: PortView shows ABVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.